These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7098615)

  • 1. [Prolactin and estrogens in osteoporosis in post-menopausal women (author's transl)].
    Rico Lenza H
    Med Clin (Barc); 1982 May; 78(9):372-5. PubMed ID: 7098615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Laboratory tests and bone biopsy in the diagnosis and treatment of osteoporosis].
    Burckhardt P
    Rev Med Suisse Romande; 1982 Jun; 102(6):599-605. PubMed ID: 7134717
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause.
    Rico H; Charro A; Depablos I; Bordiu E; Hernandez ER; Espinos D
    Clin Rheumatol; 1984 Sep; 3(3):337-43. PubMed ID: 6488712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
    La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE
    Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Involutional osteoporosis and basal levels of prolactin].
    Pedrazzoni M; Ciotti G; Davoli L; Prisco M; Costi D
    Medicina (Firenze); 1988; 8(3):320-1. PubMed ID: 3231045
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
    Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postmenopausal osteoporosis].
    Bocci A; Massobrio M; Ardizzoia M
    Minerva Endocrinol; 1985; 10(1):45-50. PubMed ID: 3903465
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine factors in senile osteoporosis.
    Okano K; Nakai R; Harasawa M
    Endocrinol Jpn; 1979 Jun; 26(Suppl):23-30. PubMed ID: 467346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Osteoporosis and the menopause].
    Amaya-León H
    Rev Colomb Obstet Ginecol; 1970; 21(1):11-22. PubMed ID: 5431439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problem of oestrogenic effect of digitalis-glycosides in women in menopause (author's transl)].
    Donát J; Jirkalová V; Kohoutek M; Rosol M; Husková M
    Cesk Gynekol; 1974 Sep; 39(8):613-5. PubMed ID: 4434528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study on metabolic effects of estriol-succinate (author's transl)].
    Strohfeldt P
    Arzneimittelforschung; 1977; 27(10):2006-8. PubMed ID: 579113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis in ovarian dysgenesis.
    Brown DM; Jowsey J; Bradford DS
    J Pediatr; 1974 Jun; 84(6):816-20. PubMed ID: 4826614
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical significance of urinary hydroxyproline determinations (author's transl)].
    Raab W
    Z Klin Chem Klin Biochem; 1972 May; 10(5):195-206. PubMed ID: 4219249
    [No Abstract]   [Full Text] [Related]  

  • 14. Ageing of bone: its relation to osteoporosis and osteoarthrosis in post-menopausal women.
    Dequeker J; Burssens A; Creytens G; Bouillon R
    Front Horm Res; 1975; 3():116-30. PubMed ID: 791695
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hyperprolactinemia on calciotropic hormones.
    Pettifor JM; Mehta AE; Delvin EE; Glorieux FH
    Med Biol; 1980 Dec; 58(6):319-21. PubMed ID: 7230913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile osteoporosis: bone findings in seven patients.
    Jowsey J; Johnson KA
    J Pediatr; 1972 Sep; 81(3):511-7. PubMed ID: 5049819
    [No Abstract]   [Full Text] [Related]  

  • 17. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of opiates in gonadotropins and prolactin secretion. Estrogens effect.
    Lo Dico G; Riggio V; Cossu A; Buscarinu G; Stoppelli I
    Panminerva Med; 1984; 26(3):157-61. PubMed ID: 6097860
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genetic polymorphism of vitamin D receptor and osteoporosis].
    Sosa Henríquez M; Torres Ramírez A; Domínguez Cabrera C; Salido E; Saavedra Santana P; Barrios Y; Limiñana Cañal JM; Betancor León P
    Med Clin (Barc); 1998 May; 110(17):646-50. PubMed ID: 9656208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.